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Background: Both gender differences (GDs) have been explored in various areas of mental 
health including disease epidemiology, treatment, risk factors and community engagement. 
However, few articles examine GDs in quality of mental health care and even fewer studies of 
quality mental health care examine process indicators. 
 
Methods: This population-based cohort study examined GDs in CIs among the adult acute 
inpatient psychiatry admissions in Ontario. The first aim of this study is to understand patterns of 
a process indicator over time by gender. The process indicators selected were control 
interventions (CIs) applied among inpatients in acute psychiatric settings across Ontario. The 
second aim is to investigate which demographic, clinical and behavioural factors are associated 
with the use of CIs for men compared to women.  
 
Analysis: Data from the Ontario Mental Health Reporting System (OMHRS), based on the RAI-
Mental Health Assessment System (RAI-MH) tool, was collected from every adult patient 
admitted to psychiatry units in Ontario. De-identified data from patients admitted between 2006-
2018 were collected from CIHI, according to their data sharing agreement. Both a gender-
stratified descriptive analysis, and a multivariable logistic regression were performed to 
understand the GDs in demographic, clinical and behavioural factors associated with the 
application of CIs.  
 
Results: Use of both restraint and confinement was more common among men compared to 
women. In addition, the logistic regression identified that odds of restraints/confinement are 
increased by levels of aggression, mania symptoms, interpersonal conflict, neurocognitive 
disorders, stimulant use and age for both men and women. Men were at a greater odds of CIs for 
stimulant use, neurocognitive disorder, mania, interpersonal conflict and moderate risk of harm 
to others. At the highest level of risk of harm to others, and when exhibiting wandering and 
elopement behaviours, women were at a greater odds of experiencing CIs. Abnormal thoughts, 
involuntary admission and history of criminal activity being associated with CI use for men only. 
Hallucinations were associated with CI use for women, but not men. The odds of CI use were 
decreased by history of trauma, challenging social relationships, and self-harm behaviours for 
both genders. Overall, these results identified GDs in patterns of restraint/confinement use 
among psychiatric inpatients and supports the continued aim to employ least-restraint approaches 
in across mental health systems in Ontario, as well as evidence of the application of behaviour-
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1.0 Introduction  
Achieving high quality mental health care involves identifying and resolving issues of 
equity. While there are numerous studies examining sex and gender differences in mental health, 
few articles examine these gender differences (GDs) in relation to the quality of mental health 
care. Good quality of care is defined as “the degree to which health care services for individuals 
and populations increase the likelihood of desired health outcomes and are consistent with 
current professional knowledge” (Funk, Lund, Freeman, & Drew, 2009; Institute of Medicine, 
2006). There is a need for sex and gender-based analysis (SGBA) in understanding whether 
desired mental health outcomes are achieved equitable for both men and women. SGBA involves 
examining the effects of both sex, the biological differences between males and females, such as 
chromosomal or physiological differences, and gender, the social, cultural and behavioural 
constructs associated with having a particular sex (Canadian Institutes of Health Research, 
2019). The terms sex and gender have been used interchangeably in mental health research. 
Throughout this study, an assumption was made that while physiological sex differences may 
influence how medications are metabolized, mental health care more often addresses and 
interacts with psychological and behavioural constructs, suggesting that gender, not sex, would 
influence the quality of care. Therefore, most studies evaluated in this review, with the exception 
of those assessing GDs in medication metabolism, were considered to be investigating the social 
constructs of gender between men and women, despite sometimes employing the sex terms 
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1.1 Gender Differences in Mental Health Literature 
 
A wealth of literature exists on GDs in the diagnosis and presentation of mental health 
disorders. For example, major depressive disorder has been consistently reported in higher rates 
among women (Picco, Subramaniam, Abdin, Vaingankar, & Chong, 2017).  Beyond diagnoses, 
GDs also exist in the severity and comorbidity of mental health disorders. For patients living 
with psychotic disorders, women have been reported to experience higher rates of comorbid 
anxiety, hallucinations and delusions, compared to men (Deligiannidis et al., 2013). GDs may 
also exist within secondary clinical factors of mental health patients. In an assessment of GDs 
among emergency department patients, a higher proportion of women were found to have a 
history of abuse, depressive disorders, self-harm behaviours, and personality disorders; in 
comparison, men were reported to have a more diagnoses of anxiety, bipolar, schizophrenia-
spectrum, and substance disorders (Juhas & Agyaponga, 2016). Expressions and outcomes of 
mental health conditions may differ by gender. For instance, men and women experience and 
express psychosis differently, with men demonstrating higher rates of disability and more trouble 
integrating into the community in comparison to women (Morgan, Castle, & Jablensky, 2008).  
GDs in the presentation of mental health disorders can influence how they are assessed 
and treated. In a cohort of 352 patients, predictors of depression were found to function 
differently between male and female participants. Women were more likely to experience and 
relapse into depressive episodes. As well, a history of a suicidal attempt was predictive of a 
depressive episode for women, but not for men (Oquendo et al., 2013).  However, among 
persons with schizophrenia, men presented with psychotic symptoms earlier than women, with 
worse functioning prior to diagnosis and a greater incidence of negative symptoms (Segarra et 
al., 2012). While women were more likely to experience acute stress one year prior to presenting 
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 3 
with psychotic symptoms and presented with more affective symptoms compared to men. 
Interestingly, even with onset of psychosis being differing between men and women, these GDs 
did not seem to affect outcomes two years after the onset of treatment (Segarra et al., 2012).  
Therefore, the presentation, diagnosis, and progression, even within the spectrum of a single 
disorder, vary between men and women, as well as across disorders. 
Some gender-based differences have also been reported in the pharmacological treatment 
of mental health disorders. For example, men are more likely to be non-compliant in their 
treatment regimens, experience involuntary admissions, and have poorer response to treatment 
(Juhas & Agyaponga, 2016). Many studies also suggest differential gender patterns in drug use, 
dependence and rehabilitation outcomes between men and women. For example, while men 
report high rates of stimulant drug use, when it comes to withdrawal, they are less symptomatic 
and have better treatment outcomes. In contrast, women reported lower rates of substance use, 
but greater severity of withdrawal symptoms including greater issues with eating, sleeping, mood 
and anxiety (Chartier et al., 2015). A similar study on cocaine use established that women 
demonstrated worse responses to treatment due to the ineffectiveness of the treatment drug 
(disulfiram) (Devito, Babuscio, Nich, Ball, & Carroll, 2014). This finding was not exclusive to 
stimulants, as confirmed by a study on cannabis withdrawal, which found that women reported 
greater mood and gastrointestinal discomfort with respect to men (Herrmann, Weerts, & 
Vandrey, 2015).  
Some researchers have attributed these GDs to discrepancies in emotional processing and 
expression that may play a role in mental illness and recovery (Judd, Armstrong, & Kulkarni, 
2009). Others explore larger systematic issues in research as being responsible for these observed 
differences. For example, women have been largely underrepresented in pharmacological 
GENDER DIFFERENCES IN RESTRAINT USE 
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studies, especially those of childbearing age. These exclusions limit our knowledge of how 
effectively medications work in both genders across the lifespan, but seem to affect women 
disproportionately (Judd et al., 2009). For example, changes that are unique to women, such as 
menstruation, menopause or pregnancy, may also influence mental health risk, in addition to, 
treatment and medication effectiveness. In a study examining the effectiveness of two 
antidepressants, menopausal status was found to alter the efficacy of the drug in women. 
Similarly, pregnancy is also considered a period of vulnerability to the onset or relapse of mental 
health disorders and decreased gastrointestinal retroflexion, which impairs effectiveness of 
medications (Vermeiden, van den Broek, Mulder, & Birkenhäger, 2010).  
There may also be nuanced differences in how gender influences engagement in mental 
health programs. In the study aforementioned, women demonstrated poorer response to cocaine-
withdrawal treatment due to the ineffectiveness of the treatment drug (disulfiram), but the same 
study found no significant differences in relation to the behavioural treatment outcomes between 
men and women, only pharmacological outcomes (Devito et al., 2014). Mental health programs 
that consider gender-specific needs are also valuable in illustrating how these differences impact 
care. For example, one study on the effectiveness of community social programming found that 
older men had low rates of involvement in mental health programs. However, participation of 
older males increased once male-focused mental health programs, with both learning and social 
aspects, were introduced. Investigators also found that recruiting for these programs before the 
age of retirement was pivotal in maintaining engagement beyond retirement (Reynolds, Roger, 
Nurmi, Urquhart, & Mackenzie, 2016). This finding is consistent with other community mental 
health studies, where men are evaluated as being more resistant to intervention, living alone, 
having less social supports, and engaging in substance use (Forchuk et al., 2009).  
GENDER DIFFERENCES IN RESTRAINT USE 
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1.2 Gender Differences in Quality of Mental Health Care Literature 
While GDs in mental health care are available, studies specifically examining GDs in the 
quality of mental health care are more scarce. In a review of literature, seven articles examining 
gender and quality of care in a mental health context were identified (See Appendix B Table 12, 
Figure 7). When comparing GDs across mental health quality indicators, the majority of articles 
fell into one of three categories: patient satisfaction, clinical care and access. Among these 
studies, quality of care was often examined through either surveys, interviews or clinical practice 
guidelines.  Five studies used either existing or newly collected data from practitioner, patient 
and national samples to evaluate care quality (Barker, Kurdyak, Jacob, & Vigod, 2018; Lam et 
al., 2017; Moore, Mompe, & Moy, 2018; Verdoux, Boulon, & Cougnard, 2008). The remaining 
two studies employed cohort study designs (Bener & Ghuloum, 2013; Robillos, Lale, 
Wooldridge, Heller, & Sarkin, 2014), with one using qualitative methods to assess patient 
perceptions of their care experiences (Bener & Ghuloum, 2013). Four studies were conducted 
using samples from the United States, and the other three studies were conducted using samples 
from Qatar, France and Canada. The quality indicators examined were patient satisfaction, 
appropriate follow-up care, clinical practices, timely receipt of care, adherence to clinical 
guidelines, proper monitoring, care access, adequate screening, and prescribing behaviours 
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1.2.1 Quality Indicators: Patient Satisfaction in Mental Health Care 
GDs in patient satisfaction were reported in two studies. Among these studies, men 
reported greater satisfaction compared to women. For instance, Bener and Ghuloum (2013) 
found gender and age may be related to satisfaction levels, with younger men reporting greater 
satisfaction with psychiatric care compared to women. Men also had greater expectations of their 
physicians in terms of providing insight to their condition, managing their symptoms and 
involving them in treatment decision-making (Bener & Ghuloum, 2013). Another nationally 
representative study of quality care established a stronger positive relationship between overall 
satisfaction and access to services, social connectedness and improved functioning for men 
rather than women (Robillos et al., 2014). Patient satisfaction measures consistently reported 
higher quality of care for men, rather than women. It appeared that men also have higher 
expectations of care. These differences could be explained by how men and women navigated 
the mental health system and negotiated their needs. Some literature suggested that women had a 
higher risk of adverse experiences in care, such as sexual assault in acute psychiatric settings. In 
some cases, women also reported their mental health concerns being met with disbelief or 
trivialization (Judd et al., 2009). This finding was surprising as men reported accessing mental 
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1.2.2 Quality Indicators: Appropriate Clinical Mental Health Care 
The majority of articles examining gender and quality of mental health care examined 
different clinical predictors of quality of care. The Canadian study, examining quality of diabetic 
care among men and women with psychotic illnesses, identified that 75% of individuals with 
psychotic illness did not receive the minimum number of diabetes-related tests as recommended 
by national guidelines. Women were more likely to receive adequate diabetic care than men 
(Barker et al., 2018) demonstrating an effect opposite to that of the patient satisfaction studies. 
Minimum care was defined as having at least four blood tests, one retinal exam and one 
dyslipidemia test within a 2-year period. As exams require patient attendance and compliance, 
this finding could be attributable to men being less adherent to treatment regimens compared to 
women (Juhas & Agyaponga, 2016). A study by Verdoux and colleagues examining the quality 
of clinical practices, explored whether patient and/or clinician characteristics influenced the 
application of metabolic monitoring guidelines of patients experiencing second-generation 
antipsychotics (SGAP) (Verdoux et al., 2008). Prior to experiencing a SGAP prescription, a 
number of metabolic tests are recommended to ensure efficacy of the medication. Follow-up 
tests are also recommended to ensure ongoing success of the drug. There are eleven tests ranging 
in complexity, from taking height and weight to requesting a blood cholesterol test. Investigators 
found that the number of metabolic parameters assessed prior to antipsychotic prescription was 
significantly lower in females and the patient gender was the only characteristic accounting for 
the discrepancy. In other words, no clinical or biological characteristics supported the use of 
fewer parameters (Verdoux et al., 2008). In another evaluation of QIs, Lam et al. examined the 
quality of depression care among veterans and found better care for women which was defined 
as adequate follow-up, appropriate prescribing, psychotherapy visits, specialist visits and 
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diagnostic evaluation within 180 days of a first visit for depression (2017). In summary, these 
studies suggest a discrepancy in adequate care and monitoring. 
Differences in treatment protocols of men and women have also been identified in other 
sources. For example, in a Swedish sample, investigators found that men with bipolar disorder 
were often treated with lithium, whereas women with the same disorder were treated with one or 
more antidepressants, lamotrigine, electroconvulsive therapy, benzodiazepines, and 
psychotherapy. While these differences may be a result of clinician and patient preferences, 
authors stated that there were no clinical or diagnostic characteristics to merit these decisions, 
suggesting that patient gender may influence clinician decisions about treatment (Karanti et al., 
2015). Similarly, Verdoux et al. found that clinician decision-making was influenced by the 
patient’s gender, rather than an evidence-based rationale. This is not to say that GDs in 
medication response do not exist; physiological sex differences accounting for differences in 
medication response have also been documented in literature. A study of antipsychotic 
prescription in veterans identified greater side effects occurring in women and this study found 
that accounting for these differences in prescribing patterns was as a means to mitigate these side 
effects (Charlotte et al., 2015; Schwartz et al., 2015). However, these discrepancies suggest an 
increased need for high quality evidence-based care in the areas of medication management, 
psychotherapeutic intervention and progress monitoring in mental health care. Finally, a study 
attempting to identify variables characterizing both helpful and unhelpful experiences in therapy-
seeking LGBT patients found that client-level variables, service-level variables and therapist 
behaviors affected experiences of LGBT individuals in therapy. Variables associated with 
helpful therapy experiences included type of practitioner, referral source, practice setting, 
practitioner response to client sexual orientation and accommodating client needs. 
GENDER DIFFERENCES IN RESTRAINT USE 
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1.2.3 Quality Indicators: Mental Health Care Access 
A study analyzing GDs and trends in health care access as a part of the National Quality 
Strategy, found that women received worse mental health care than men 20% of the time and 
equal or better care 80% of the time. However, women also experienced more barriers to care, in 
particular financial barriers or inconsistent health coverage. Where women achieved the same 
mental health outcomes as men, they also received more services to achieve these similar 
outcomes (Moore et al., 2018). However, men reported accessing mental health services less 
frequently, due to stigma and mistrust of the system (Ojeda & Bergstresser, 2008). While women 
may not access care due to external barriers, such as limited finances. LGBTQ+ patients also 
avoid accessing services due to mistrust rooted in discriminatory practices relating to their sexual 
orientation. In an Irish sample of LGBTQ+ adults, qualitative analyses revealed that due to lack 
of practitioner knowledge on LGBTQ+ issues, only 37% of patients were not comfortable 
sharing their gender and sexual orientations with their practitioners (Mccann & Sharek, 2014). 
Therefore, financial barriers, stigma and discrimination were identified, through an analysis of 
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1.3 Gaps in Quality of Mental Health Care Research 
All quality indicators fall into one of three categories: structure, process and outcome 
factors. Structure measures relate to systematic issues, such as access to care. Process measures 
include actions influencing provision of care, such as interventions implemented during a 
hospital stay. Finally, outcome measures are developed and based on common assessment 
systems, they provide feedback on performance and may include patient outcomes or satisfaction 
(Donabedian, 1966).  
Process measures were limited in this literature review and as such, will be the focus of 
this thesis. Understanding process measures in quality of care provides potential areas of 
improvement that can be targeted to achieve desired outcomes. Good process measures, or 
indicators, often relate to larger goals of quality and are identified through empirical research and 
evaluation. One example is the Quadruple Aim, which is a framework by which to improve 
quality of care by targeting four factors: patient experiences, population health, reducing costs 
and well-being of the health care team (Berwick, Nolan, & Whittington, 2008). These four areas 
work synergistically as improvements in one area affect the other three. According to the 
Quadruple Aim, effective improvements in care require a defined population and depend on 
supportive policies, adequate resources and responsive feedback indicators for continual 
progress. Another similar framework involves the six dimensions outlined by the IOM: “safety, 
effectiveness, patient centeredness, timeliness, efficiency, and equity” (Berwick et al., 2008). 
Within these dimensions and frameworks, a number of variables may exist that can measure 
quality of health care and even act as targets for improvement, these are known as quality 
indicators. 
A number of mental health quality indicators (QIs), also known as performance 
GENDER DIFFERENCES IN RESTRAINT USE 
 11 
indicators, have been identified in literature. A recent report by the Centre for Applied Research 
in Mental Health and Addictions (CARMHA) identified 63 meaningful mental health QIs (Jones, 
Goldner, Butler, & McEwan, 2015). A systematic inventory identified 1480 unique QIs, many of 
which were related to the processes of delivering mental health care (Lauriks, Buster, De Wit, 
Arah, & Klazinga, 2012).  QIs are used to gage the effectiveness and efficiency of mental health 
care, by answering questions regarding use, misuse, overuse or underuse of services (Farquhar, 
2008). Some examples of mental health QIs include hospital readmissions within 30 days of 
discharge, utilization of outpatient services and patient satisfaction (Butler et al., 2017; Jones et 
al., 2015). High hospital readmission rates, for example, could indicate inadequate provision of 
resources in-hospital or poor discharge planning and initiate a response from administrators to 
improve the performance of the hospital. While the majority of mental health services in Canada 
are provided through publicly funded avenues, the application of QIs is not consistent across the 
nation. While there are efforts to standardize quality of care measures across the country, such as 
the interRAI consortium, development of QIs often varies by context, organization and necessity 
(Lauriks et al., 2012). Mental health quality indicators can be derived from existing assessments, 
patient feedback, facility resources processes of care or outcomes. Well-established QIs may 
translate into clinical care through the development of care standards that ensure quality is 
maintained in practice. Standards of care have been developed different areas of mental health 
for the following problem areas: managing depression and/or anxiety disorders, transitions 
between inpatient mental health settings and home; and schizophrenia care in the community 
(Health Quality Ontario, 2019). For the purposes of this thesis, the QI selected will be control 
intervention use, as it is both a QI and standards of care already exist for this in-hospital process. 
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1.4 Control Interventions as a Process Measure in Acute Psychiatry 
As a well-established QI, the use of control interventions (CIs) is a good process 
indicator to explore GDs in acute psychiatric care. CIs are an interesting variable because their 
use involves difficult judgment calls based on staff perceptions of and interactions with the 
patient. CIs encroach on patient autonomy and can generate both patient and staff safety issues. 
The complexity of this in-hospital process makes it an interesting variable for a gender-based 
analysis and a good variable for examining quality of mental health care because reductions in 
QIs are already established as a quality-of-care goal in psychiatric settings. 
CIs are used in several areas of medicine to limit movement of an individual who pose an 
acute risk of harm to themselves or others (Negroni, 2017). CIs may involve physical, 
mechanical and chemical restraints as well as confinement. Physical restraints involve staff 
limiting movement by making physical contact with the patient (Mah, Hirdes, Heckman, & 
Stolee, 2015). The terms physical and mechanical restraint are sometimes used interchangeably, 
however, mechanical restraint can be distinguished as limiting patient movement through the use 
of a mechanism, such as a belt, chair-that-prevents-rising, elevated bed rails and other devices. 
Chemical restraints are medications provided to temporarily sedate or tranquilize patients with 
the goal of behaviour management (Mah et al., 2015). Finally, several forms of confinement are 
also considered CIs and include preventing patients from leaving a room, unit and/or remaining 
under observation, which is also referred to as time spent in a seclusion room (Negroni, 2017). 
The use of restraints is controversial, and there has been a movement towards employing 
behaviour management techniques and minimizing the use of CIs. These behaviour management 
techniques focus on understanding the patient’s needs and manipulating their surroundings to 
create a safer environment for both staff and patients (College of Nurses of Ontario, 2018). One 
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reason why restraint use is contested lies in the potential for subjectivity behind the decision to 
restraint. Restraint and confinement use may also worsen patient outcomes, in particular for 
patient with a history of trauma and/or self-harm (Emmanuel et al., 2013). Best practices have 
moved towards a least restraint approach, to improve patient outcomes, and to mitigate the 
disproportionate restraining patients with younger age, an immigrant background, bipolar and 
personality disorders (Dumais, Larue, Drapeau, Ménard, & Giguère Allard, 2011; Knutzen, 
Sandvik, Hauff, Opjordsmoen, & Friis, 2007). However, evidence suggests that CIs continue to 
be used as an automatic response for disruptive behaviour, rather than for their intended use: 
responding to acute safety issues. More research is needed to evaluate how restraint and 
confinement use as changed over time, since the advent of these least-restraint policies in the 
early 2000s (College of Nurses of Ontario, 2018). This discrepancy makes CIs an ideal process 
measure to examine GDs because some studies suggest a higher rate of restraint in males, other 
studies suggest higher restraint use in females (Dumais et al., 2011). Yet, other studies suggest 
no relationship between restraint and gender, however, a few studies have alluded to associations 
between gender and other variables, many of which remain unexplored (Dumais et al., 2011; 
Knutzen et al., 2007). 
 
1.5 Purpose 
The purpose of this study was to investigate GDs in the quality of mental health care 
using the CIs as a quality indicator. The first aim was to evaluate patterns of CIs over time by 
gender, and the second aim was to identify which demographic, behavioral and clinical 
characteristics are associated with the application of CIs for men compared to women. 
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2.0 Methods 
2.1 Data Source  
Data from inpatient mental health visits were obtained from the Ontario Mental Health 
Reporting System of the Canadian Institute for Health Information (OMHRS). The OMHRS is 
based on the RAI-Mental Health Assessment System (RAI-MH), which is a valid and 
standardized instrument for assessing persons admitted to inpatient psychiatric settings (Hirdes et 
al., 2008, 2002, 2020). This instrument was developed by global experts through a series of 
systematic steps, including research, application and evaluation, to address the broad needs of 
psychiatric populations (Hirdes et al., 2002). The RAI-MH is administered by trained health care 
professionals across 14 different facilities and acceptable reliability cut-offs were established 
using conservative methods across all domain areas (Hirdes et al., 2002). The Ontario Ministry 
of Health and Long-Term Care has mandated that the RAI-MH be completed for adults admitted 
to inpatient psychiatry. The data are stored and managed by the Canadian Institute for Health 
Research (Canadian Institute for Health Information, 2019). Items are assessed over a 3-day 
period by trained medical staff, and may include statements by the patient, family accounts, 
provider interactions or medical history, strengthening the validity of the assessment (Hirdes et 
al., 2002). The RAI-MH includes a number of sub-scales, which have been validated against 





GENDER DIFFERENCES IN RESTRAINT USE 
 15 
 
2.2 Study Population 
The study population included adults, aged 18 and over, admitted to acute inpatient 
psychiatric beds in Ontario between 2006-2018, with no prior admissions. De-identified data 
from patients were available from CIHI and the most recent admission and discharge for each 
patient was isolated for analysis. Patients with forensic admissions were excluded as their care 
trajectories are determined by the judicial system and differ from community mental health 
admissions.  
The gender distribution within the OMHRS data is evenly split between men and women, 
making it an ideal sample for assessing gender differences (GDs). The population is 
representative of patients admitted to acute inpatient psychiatry in Ontario. This dataset includes 
close to no non-response bias as the assessments are mandated and conducted for every 
admission by a health care professional. The exception is patients who leave against medical 
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2.3 Independent Variables 
2.3.1 Demographic Variables 
2.3.1.1 Age 
The continuous age variable was collapsed into six categories, 18-24, 25-34, 35-44, 45-
54, 55-64 and 65+, with age group 18-24 as the reference variable. Patients younger than 
18 years were removed from the sample they would be cared for in child psychiatric 
units, with different resources and supports available. These cut-offs were based on cut-
offs traditionally used in previous literature, however, alternative cut-offs as well as a 
continuous variable could have been used.  
2.3.1.2 Gender 
The dataset included male, female and other. Male and female were re-labelled as men 
and women, respectively, to reflect a gender variable. Patients identifying as “other” were 
not included as they accounted for only 0.0003% of the population (n=22) with only two 
of these patients experiencing CIs (one restraint and one confinement), preventing any 
statistically/clinically significant analysis. In addition, due to residual disclosure in 
deidentified data, analysis of cell counts below five cannot be done as these patients 
could be identify, jeopardizing patient privacy.  
2.3.1.3 Marital Status 
Marital status was collapsed into three categories: never married, married and separated, 
which included divorced or widowed, with never married as the reference variable. 
Married and partner/significant other were collapsed into the married category. These 
variables were included as proxies to capture support systems which may be available to 
patients. An alternative category would have been to separate widowed and separated 
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patients as the support systems of widowers differ from their separated or divorced 
counterparts as the nature of their loss may not include interpersonal conflict with family 
members and isolation. 
2.3.1.4 Living Status 
Living status was collapsed into three categories, lived alone, lived with others and 
homeless, with homelessness as the reference variable. “Lived with others” included 
lived with spouse only, lived with spouse and other(s), lived with children, lived with 
others and lived in a group setting. These variables were included as proxies to capture 
support systems which may or may not be available to patients. 
2.3.1.5 Employment Status 
Employment status was collapsed into three categories: unemployment, employed and 
other, with unemployment as the reference variable. “Unknown” employment status was 
removed as it only accounted for 2.5% of patients and was not descriptive. 
2.3.1.6 Education 
Education status was captured in three categories: completed less than high school, 
completed high school or pursued post-secondary education, with less than high school 
education as the reference variable. “Less than high school” included no schooling, 
grades 8 or less and grades 9-11. “Pursued post-secondary education” included technical 
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2.3.2 Primary Diagnosis 
The RAI-MH captures diagnostic categories from the Diagnostic and Statistical Manual 
of Mental Disorders (DSM); these diagnoses are assigned and/or confirmed by the psychiatrist 
overseeing the care of the admitted person. Admissions prior to 2016 were coded using the 
previous version of the DSM, the DSM-IV. Admissions after 2016 were coded using the current 
DSM-V (American Psychiatric Association, 2000, 2013). To account for this change, categories 
in the DSM-V were cross-walked to their correlated variable in the DSM-IV. Primary diagnoses 
under 5% prevalence were collapsed into an “Other Diagnosis” category, with the exception of 
Neurocognitive and Neurodevelopmental Disorders. The final diagnoses categories included 
Substance Use, Schizophrenia, Mood Disorders, Anxiety Disorder, Personality Disorder, 
Neurocognitive and Neurodevelopmental Disorders. These variables were dichotomized as 
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2.3.3 Clinical Symptoms and Scale 
Hallucinations, command hallucinations, delusions and abnormal thoughts were included 
as dichotomous variables, indicating presence of the symptom in the last three days or absence of 
the symptom. Scales were categorized into low, moderate and high levels.  
2.3.3.1 Cognitive Performance Scale (CPS) 
The CPS ranges from 0-6, with higher scores indicating more severe cognitive 
impairment by considering memory, decision-making and communication. The CPS was 
converted into a categorical variable with three groups, 0-2, 3-4 and 5-6. 
2.3.3.2 Positive Symptom Scale (PSS)  
The PSS ranges from 0-12, with higher scores indicating higher number and frequency of 
the following positive symptoms: hallucinations, command hallucinations, delusions and 
abnormal thoughts. The PSS was converted into a categorical variable with three groups, 
collapsing scales into 0-2, 3-6 and 9-12. 
2.3.3.3 Depressive Severity Index (DSI) 
The DSI ranges from 0-15, with higher scores indicating more severe impairment due to 
depressive symptoms, this scale considers affect, negative statements and feelings of 
hopelessness. The DSI was converted into a categorical variable with three groups, 
collapsing scales into 0-2, 3-8 and 9-15. 
2.3.3.4 Mania Scale  
The Mania Scale ranges from 0-18, with higher scores indicating more severe manic 
symptoms. This scale sums six items including: inflated self-worth, hyper-arousal and 
increased sociability. The Mania Scale was converted into a categorical variable with 
three groups, collapsing scales into 0-2, 3-5 and 6-18. 
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2.3.4 Behavioural Variables 
The RAI-MH includes a number of items assessing behaviours and violence, such as 
wandering, verbal abuse, physical abuse, disruptive behaviour, inappropriate sexual behaviour, 
resisting care and elopement attempts. These items are combined into several sub-scales, such as 
the Aggressive Behaviour Scale and Risk of Harm to Others Scale (see Appendix A, Table 10). 
Wandering and elopement, which are not included in any scale, were left in their original 
increments: no incident of the behaviour, incidents of the behaviour, but not in the last three days 
incidents of the behaviour within the last three days and daily incidents of the behaviour.  
2.3.4.1 Substance Use 
The RAI-MH includes items on the recent of the use of inhalants, hallucinogens, cocaine, 
stimulants, opiates, cannabis, problematic alcohol use, smoothing and misuse of 
medication. Each category was dichotomized into experienced/used in the last month or 
no experience/use in the last month. Additional substance use categories included 
withdrawal and misuse of medications.  
2.3.4.2 Risk of Harm to Others (RHO) Scale  
The RHO scale ranges from 0-6, with higher scores indicating higher risk of harm to 
others by considering levels of violence and aggression (Neufeld, Perlman, & Hirdes, 
2012). The RHO was converted into the three categorical groups, 0-2, 3-4 and 5-6. 
2.3.4.3 Severity of Self-Harm (SOS) Scale  
The SOS scale ranges from 0-6, with higher scores indicating higher risk of self-harm 
and/or suicide by considering previous history of self-harm, depressive and psychotic 
symptoms (Hirdes et al., 2002). The SOS scale was converted into a categorical variable 
with three groups, collapsing scales into 0-2, 3-4 and 5-6. 
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2.3.2.4 Aggressive Behaviour Scale (ABS) 
The ABS ranges from 0-12, with higher scores indicating higher levels of aggression by 
considering verbal, abuse, physical abuse and other disruptive behaviours. The ABS was 
converted into a categorical variable with three groups, 0-2, 3-6 and 7-12.  
2.3.2.5 Clinical Assessment Protocols (CAPs) 
CAPs are designed to assist clinician decision-making as to whether and how to intervene 
with the individual by facilitating interpretation of key issues identified during the 
assessment process (InterRAI, 2020).  The CAPs were retained in their original 
increments, ranging from 0-2 or 0-1. Appendix A, Table 11 summarizes the CAPs used 
in this study. CAPs ranging from 0-2 included: harm to others (Harm CAP), suicidality 
and purposeful self-harm (Self-Harm CAP), interpersonal conflict (Conflict CAP), social 
isolation and family dysfunction (Social CAP), traumatic life events (Trauma CAP) and 
substance use (Substance Use CAP). Only the criminal activity dichotomous CAP (0-1) 
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2.4 Dependent Variables 
2.4.1 Any Control Intervention 
This variable includes application of any mechanical restraints, physical restraints, chair 
that prevents rising, confinement to a room or use of a seclusion room. All CIs were 
dichotomized as occurring in any duration (1) or not occurring at all (0). The variable 
“confinement to unit” was removed as the majority of inpatient psychiatric settings include 
locked units, nevertheless patients are free to move inside the unit. As a result, including the 
confinement to the unit as a whole could skew the analysis by inflating the prevalence of CIs. 
While data on chemical restraints was available in the dataset, they were not a focus of this study 
and thus not included in this variable or in the analysis. 
2.4.2 Mechanical Restraint 
Mechanical restraint involves restricting patient movement by using a device, such as bed 
straps. The levels of mechanical restraint were dichotomized into any mechanical restraint 
applied (1) and no mechanical restraint (0). 
2.4.3 Chair that Prevents Rising 
A chair that prevents rising is any chair that would prevent the patient from rising 
independently. The levels of this type of restraint were dichotomized into any chair restraint 
applied (1) and no chair restraint (0). 
2.4.4 Physical Restraint by Staff 
Physical or manual restraint refers to limiting the patient’s movement through direct 
contact with the patient by a staff member. The levels of this type of restraint were dichotomized 
into any use of physical restraint (1) and no physical restraint (0). 
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2.4.5 Confinement to a Unit  
A patient confined to a unit cannot leave the hospital psychiatric unit or can only leave 
with special permission and/or restrictions. The frequency of this type of confinement was 
dichotomized into any confinement to a unit (1) and no confinement to a unit (0). This type of 
confinement was not included in some components of the analysis as the majority of inpatient 
psychiatric patients are confined to a unit in hospital for at least a portion of their admission. As 
such, this could artificially inflate the number of patients who are “confined”. 
2.4.6 Confinement to a Room 
Patients at risk of harming themselves are sometimes confined to an individual room on 
the psychiatric unit. These rooms may be monitored but do not fit criteria for “seclusion rooms”. 
The frequency of this type of confinement was dichotomized into any confinement to a room (1) 
and no confinement to a room (0). 
2.4.7 Seclusion Room 
Seclusion rooms are high security areas for patients who are a significant risk to others. 
These rooms are monitored, and staff enter on periodically to provide support to patients. The 
frequency of this type of confinement was dichotomized into any confinement to a seclusion 
room (1) and no confinement to a seclusion room (0). 
2.4.8 Any Restraint 
Dichotomous variables were also created to capture use of any type restraint. This 
variable includes application of any mechanical restraints, physical restraints and/or chair that 
prevents rising. This variable was dichotomized as occurring in any duration (1) or not occurring 
at all (0). 
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2.4.9 Any Confinement 
Dichotomous variables were also created to capture use of any type confinement. This 
variable includes confinement to a room or use of a seclusion room. Once again, confinement to 
a unit was not included as many inpatients are confined to a unit in hospital for at least a portion 
of their admission. This variable was dichotomized as occurring in any duration (1) or not 
occurring at all (0).  
 
2.5 Analysis  
The Office of Research Ethics at the University of Waterloo provided the ethics clearance 
for this study on May 26th, 2020 under the ORE file number 41965. All analyses were conducted 
using Statistical Analysis Software (SAS) 9.4. A descriptive analysis was conducted by 
generating frequency tables between gender, CIs, and demographic, diagnostic, behavioural and 
clinical variables. To understand patterns of CI use over time, graphical analysis was conducted 
between time in years, gender and types of CIs. This analysis was repeated with patients with 
SOS and RHO scores >3 to assess whether those at higher risk of restraint differ in proportions 
of restraint, compared to those at lower risk (Figures 2 and 3). To evaluate GDs in CI use, a 
stratified multivariable logistic regression was performed for both genders, adjusting for 
demographic, behavioural and clinical factors, which were blocked separately. Variables that 
were not statistically significant, or having a p-value greater than 0.05, were removed at each 
block. The C-statistic was used to assess goodness-of-fit for the final models. 
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3.0 Results 
3.1 Gender Differences in Descriptive Analysis Findings  
There were 55,013 first admissions occurring between January 1, 2006 and December 31, 
2018. First admissions were selected to control for previous hospital exposure, rapport with staff 
or prior CI experiences that may influence interventions for more recent admissions. Descriptive 
characteristics of these patients can be found in Table 1. The population was evenly divided 
between men (49.2%) and women (50.8%). Both the mean and median ages were 41 (SD=15) 
for men and 45 (SD=16) for women, with the largest proportion of patients falling between 45-
54 for both genders. There were more women present in older age groups and more men in 
younger age groups. Over 60% of the first-admission acute psychiatric inpatient lived with 
others, with 35% and 33% of men and women living alone, respectively. Less than 4% of the 
sample reported homelessness, with men experiencing slightly higher proportions of 
homelessness (4.4%). Most patients where educated, with 45% of men and 52% of women 
having either completed or pursued some college/university education. Around 30% of both men 
and women completed high school and just under, 25% of men and 20% of women had 
completed less than a high school education. While men and women were employed in equal 
proportions (17%), a 62 % of men and 60% of women were unemployed. 
The most common primary diagnoses among first-admission acute psychiatric inpatients 
were schizophrenia spectrum (43%) and substance use (34%) disorders. Among women the most 
common primary diagnoses were anxiety (3.9%), mood, (50.3%) personality (4.1%), other 
disorders (3.6%). Likewise, more women experienced elevated DSI scores in comparison to 
men. In contrast, men were diagnosed more often with schizophrenia-spectrum (40.6%), 
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substance use (11%), neurocognitive (2.7%) and neurodevelopmental disorders (1.3%). Men also 
exhibited more individual symptoms for hallucinations, delusions and abnormal thoughts as well 
as scored higher on the PSS when compared to women. Based on scores on the CPS, the 
majority of patients experienced mild to no cognitive impairment; however, higher scores were 
more common among men compared to women.  The proportions of men and women 
experiencing mania symptoms were similar.   
Behavioural GDs were consistent with diagnostic trends. For example, substance use was 
more common among men than women, with the exception of medication misuse, in which case 
the number of women exceeded men by about 4%.    
The proportion of men with aggressive, violent and disruptive behaviours exhibited by 
men was higher than women, as demonstrated by higher scores on the RHO, ABS and individual 
wandering/elopement behaviours. On the other hand, women score higher levels on the SOS 
scale more often than men. The CAPs mirrored trends in the individual behavioural disturbances 
as well. More men triggered the Harm to Others (16.9%), Substance Use (47.1%) and Criminal 
Activity (39.7%) CAPs, whereas women triggered Self-Harm (28.5%) and Trauma (8.8%) 
CAPs. The most notable GDs occurred in the Criminal Activity CAP, with 16% more men 
triggering this CAP than women and the Substance Use CAP, exhibiting a 12% discrepancy 
between the genders. Apart from criminal activity, the GD between men and women ranged from 
about 2-5%. Men and women exhibited similar rates at all levels of both the Social Relationship 
and Interpersonal Conflict CAPs. 
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Table 1 Descriptive Analysis of Adult Mental Health First-Admission Inpatient Characteristics, Ontario 2006 – 2018 (N = 55,013) 
 Demographic Characteristics 
Gender n (%) Men n=27069 (49.2) Women n=27944 (50.8) All n=55013 (100) 
Age Mean/Median (SD) 41/40 (15) 45/45 (16)  
Age Distribution n (%)    
18-24   4633 (17.1) 3612 (12.9) 8245 (15.0) 
25-34  6125 (22.6) 4644 (16.6) 10769 (19.6) 
35-44  4951 (18.4) 5157 (18.5) 10108 (18.4) 
45-54  5327 (19.7) 6284 (22.5) 11611 (21.1) 
55-64  3689 (13.6) 4681 (16.8) 8370 (15.2) 
65+  2344 (8.7) 3566 (12.8) 5910 (10.7) 
Living Status n (%)    
Homeless  1196 (4.4) 767 (2.7) 1963 (3.56) 
Alone  9521 (35.2) 9299 (33.3) 18820 (34.2) 
With Others  16352 (60.4) 17878 (64.0) 34230 (62.3) 
Marital Status n (%)    
Never married 17687 (65.3) 12576 (45.0) 30263 (55.0) 
Married or SO 5375 (19.9) 8630 (30.9) 14005 (25.7) 
Widowed or Separated 4007 (14.8) 6738 (24.1) 10745 (19.5) 
Education n (%)    
< High School 6775 (20.4) 5710 (25.0) 12485 (22.7) 
High School 8026 (27.3) 7614 (29.3) 15640 (28.4) 
> High School 12268 (45.3) 14620 (52.3) 26888 (48.9) 
Employment n (%)    
Unemployed 17034 (62.9) 16688 (59.7) 33722 (61.3) 
Employed 4769 (17.6) 4980 (17.8) 9749 (17.7) 
Other 5266 (19.5) 6276 (22.5) 11542 (21.0) 
    




Table 1 Con^t Descriptive Analysis of Characteristics of Adults at First Psychiatric Admission, Ontario 2006 – 2018 (N = 55,013) 
 
 Clinical Characteristics 
 Men n=27069 (49.2) Women n=27944 (50.8) All n=55013 (100) 
Involuntary Admission n (%) 4507 (16.7) 4230 (15.1) 8737 (15.9) 
Hallucinations n (%) 6126 (22.6) 4990 (17.9) 11116 (20.2) 
Command Hallucinations n (%) 2053 (7.6) 1573 (5.6) 3626 (6.6) 
Delusions n (%) 8525 (31.5) 7536 (27.0) 16061 (29.2) 
Abnormal Thoughts n (%) 10564 (39.0) 9573 (34.3) 20137 (36.6) 
Primary Diagnosis n (%)    
Substance Use 2973 (11.0) 1818 (6.5) 18814 (34.2) 
Schizophrenia  10983 (40.6) 7831 (28.0) 24013 (43.7) 
Mood Disorders  9971 (36.8) 14042 (50.3) 1896 (3.5) 
Anxiety Disorder  805 (3.0) 1091 (3.9) 1568 (2.9) 
Personality Disorder  421 (1.7) 1147 (4.1) 1717 (3.1) 
Neurocognitive Disorders 719 (2.7) 691 (2.5) 4791 (8.7) 
Neurodevelopmental Disorders 361 (1.3) 202 (0.7) 1410 (2.6) 
Other 723 (2.7) 994 (3.6) 563 (1.0) 
Cognitive Performance Scale n (%)    
0-2 25166 (93.0) 25922 (92.8) 51088 (92.8) 
3-4 1222 (5.0) 1388 (4.5) 2610 (4.7) 
5-6 634 (2.5) 681 (2.3) 1315 (2.4) 
Positive Symptoms Scale n (%)    
0-2 15144 (56.0) 17478 (62.6) 32622 (59.3) 
3-6 8600 (31.8) 7822 (28.0) 16422 (28.9) 
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Table 1 Con^t Descriptive Analysis of Characteristics of Adults at First Psychiatric Admission, Ontario 2006 – 2018 (N = 55,013) 
 
 Clinical Characteristics Con^t 
 Men n=27069 (49.2) Women n=27944 (50.8) All n=55013 (100) 
Depression Severity Index n (%)    
0-2 13543 (50.0) 11110 (39.8) 24653 (44.8) 
3-8 10504 (38.8) 12198 (43.7) 14901 (41.3) 
9-15  3022 (11.2) 4636 (16.6) 15459 (13.9) 
Mania n (%)    
0-2 16397 (60.6) 16977 (60.8) 33374 (60.7) 
3-5 4751 (17.6) 4908 (17.6) 7877 (17.7) 
6-20 5921 (21.9) 6059 (21.7) 13762 (21.8) 
Substance Use n (%)    
Recent Inhalant Use 227 (0.8) 104 (0.4) 331 (0.6) 
Recent Hallucinogens 469 (1.7) 234 (0.8) 703 (1.3) 
Recent Cocaine 2106 (7.8) 1335 (4.8) 3441 (6.3) 
Recent Stimulants 1259 (4.7) 732 (2.6) 1991 (3.6) 
Recent Opiates 1414 (5.2) 1156 (4.1) 2570 (4.7) 
Recent Cannabis 7049 (26.0) 3970 (14.2) 11019 (20.0) 
Problematic Alcohol Use 4214 (15.6) 2616 (9.4) 6830 (12.4) 
Smoking 12656 (46.8) 9596 (34.3) 22252 (40.3) 
Misuse of Medications 3406 (12.6) 4572 (16.4) 7978 (14.5) 
Withdrawal 2738 (10.1) 1963 (7.0) 4701 (8.6) 
Any Substance Use 8547 (31.6) 5206 (18.6) 13753 (25.0) 
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Table 1 Con^t Descriptive Analysis of Characteristics of Adults at First Psychiatric Admission, Ontario 2006 – 2018 (N = 55,013) 
 
 Behavioural Characteristics Con^t 
 Men n=27069 (49.2) Women n=27944 (50.8) All n=55013 (100) 
Individual Behaviours n (%)    
Wandering 2826 (10.4) 2618 (9.4) 5444 (9.8) 
Elopement 1932 (7.1) 1787 (6.4) 3719 (6.8) 
    
Risk of Harm to Others Scale n (%)    
0-2 17607 (65.0) 20696 (74.1) 38303 (69.6) 
3-4 4896 (18.1) 4446 (15.9) 9342 (17.0) 
5-6 4566 (16.9) 2802 (10.0) 7368 (13.4) 
Severity of Self Harm Scale n (%)    
0-2 16023 (59.2) 15121 (54.1) 31144 (56.6) 
3-4 4343 (16.0) 4874 (17.4) 9217 (16.8) 
5-6 6703 (24.8) 7949 (28.5) 14652 (26.6) 
Aggressive Behaviour Scale n (%)    
0-2 22076 (81.6) 23488 (84.1) 45564 (82.8) 
3-6 2377 (8.8) 2060 (7.4) 4437 (8.1) 
7-12 2616 (9.7) 2396 (8.6) 5012 (9.1) 
    
Clinical Assessment Protocols n (%)    
Harm to Others CAP    
0  16674 (61.6) 20164 (72.2) 36838 (67.0) 
1 5829 (21.5) 4978 (17.8) 10807 (19.6) 
2 4566 (16.9) 2802 (10.0) 7368 (13.4) 
Suicidality and Purposeful Self-Harm CAP    
0  16635 (61.5) 15796 (56.5) 32431 (59.0) 
1 3731 (13.8) 4199 (15.0) 7930 (14.4) 
2 6703 (24.8) 7949 (28.5) 14652 (26.6) 
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 Men n=27069 (49.2) Women n=27944 (50.8) All n=55013 (100) 
Traumatic Life Events CAP    
0  24210 (89.4) 22777 (81.5) 46987 (85.4) 
1 1762 (6.5) 2713 (9.7) 4475 (8.1) 
2 1097 (4.0) 2454 (8.8) 3551 (6.5) 
Social Relationships CAP    
0  12824 (47.4) 12890 (46.1) 25714 (46.7) 
1 7311 (27.0) 7646 (27.4) 14957 (27.2) 
2 6934 (25.6) 7408 (26.5) 14342 (26.1) 
Interpersonal Conflict CAP    
0  16582 (61.3) 17571 (62.9) 34153 (62.1) 
1 7055 (26.1) 6936 (24.8) 13991 (25.4) 
2 3432 (12.7) 3437 (12.3) 6869 (12.5) 
Criminal Activity CAP    
0 16334 (60.3) 21406 (76.6) 37740 (68.6) 
1 10735 (39.7) 6538 (23.4) 17273 (31.4) 
Substance Use CAP    
0  12709 (47.0) 17109 (61.2) 29818 (54.2) 
1 1612 (6.0) 1097 (4.0) 2709 (4.91) 
    
    
Note: A description of each CAP can be found in Appendix A, Table 11 
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3.2 Descriptive Analysis of Control Interventions 
Of the first-admission acute psychiatric inpatient population, 2667 (9.9%) men and 1897 
women (6.8%) experienced the use of a CI, respectively. Both restraint and confinement rates 
had appeared to remain steady over time, hovering at about 10% for men and 7% for women 
(Figure 1). CI rates for men remained 3% higher on average than CI rates for women. Among 
patients who were at risk of harm to others, men also experienced proportionately higher CIs, 
however, between 2011 and 2014, rates of CI for men and women were relatively equal. For 
patients at a risk of harm to themselves, the overall proportion of CIs was lower, with more men 
experiencing CIs on average. At certain intervals, 2008-2009 and 2011-2012, CI rates among 
patients with an SOS>3 were similar (Figure 2). Table 2 demonstrates that among the sample of 
men about 5% of the CIs applied were restraints and 11% were confinement interventions. In 
comparison, of the CIs applied to women, less than 4% were restraints and 8% were confinement 
interventions (Table 2). 
 
Table 2 Proportion of CI Use Among Adult Mental Health First-Admission Inpatients by Gender 






Any Control Intervention n (%) 2667 (9.9) 1897 (6.8) 4564 (8.3) 
Any Restraint n (%) 1367 (5.0) 1024 (3.7) 2391 (4.4) 
Any Confinement n (%) 3063 (11.3) 2325 (8.3) 5388 (9.8) 
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When considering proportional CI use (Table 4), men experienced CIs more often than 
women for all demographic variables. Even in categories where there were more women, men 
were still restrained and/or confined in higher numbers. For example, while there were more 
women over the age 44, men were restraint/confined up to 8.8% more often in these age groups. 
When examining restraints and confinement separately, the highest prevalence was among men 
in the youngest (18-24) and oldest age groups (65+). For martial, living educational and 
employment status, the GD in CIs averaged around 3.6%. This difference was lower for 
restraints only (1.3%) and confinement only (2.7%). In general, the difference in CIs between 
men and women for all demographic variables was under 4%.  
CIs were also experienced by more men across most diagnoses, with the exception of 
restraint use among those with anxiety disorders (0.7% more women) and any CI among those 
with schizophrenia-spectrum disorders (0.9% more women), however in the case of the later, the 
frequency of men being restrained was considerably higher (See Table 5). Patients exhibiting 
high risk of harm to others has also remained steady between 2006 and 2018, averaging around 
60% for men. There were greater fluctuations in risk of harm among women, but the prevalence 
of women scoring an RHO>3 has declined, more recently averaging around 40% (See Figure 4; 
Figure 5). From the data in Table 6, restraint/confinement use was higher among men for all 
clinical symptom scales as well, despite women having higher scores on some scales, such as the 
DSI. When examining proportions of behaviours and CI use men experienced CIs more often 
than women, despite more women occupying Self-Harm and Trauma CAPs (Table 6) and 
























Figure 1 Use of CI among adults at First-Admission to Inpatient Psychiatry in Ontario, by 
Gender between 2006 – 2018 
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Table 3 Proportion of CI Use among patients with RHO >3/SOS >3 at First-Admission to Inpatient Psychiatry by Gender 
 Any Control Intervention Any Restraint Any Confinement  
 Men (n=2667) Women (n=1897) Men (n=1367) Women (n=1024) Men (n=3063) Women (n=2325) 
RHO ≥ 3 719 (4.1) 610 (3.0) 290 (1.7) 274 (1.3) 1077 (6.1) 994 (4.8) 
RHO >3 1948 (20.6) 1287 (17.8) 1077 (11.4) 750 (10.4) 1986 (21.0) 1331 (18.4) 
       
SOS ≥3 1747 (10.9) 1112 (7.4) 871 (5.4) 584 (3.9) 1898 (11.9) 1290 (8.5) 
SOS >3 920 (8.3) 785 (6.1) 496 (4.5) 440 (3.4) 1165 (10.6) 1035 (8.1) 
Note: A description of RHO and SOS scales can be found in Appendix A, Table 10 
 
 
 Figure 2 Use of CI among adults at First-Admission to Inpatient 
Psychiatry in Ontario with RHO >3, by Gender between 2006 – 2018 
Figure 3  Use of CI among adults at First-Admission to Inpatient 
Psychiatry in Ontario with SOS >3, by Gender between 2006 – 2018 
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Table 4  Proportion of CI Use Among Adult Mental Health First-Admission Inpatients by Gender and Demographic Characteristics 













18-24   655 (14.1) 292 (8.1) 353 (7.6) 141 (3.9) 737 (15.9) 367 (10.2) 
25-34  680 (11.1) 357 (7.6) 325 (5.3) 204 (4.4) 816 (13.3) 430 (9.3) 
35-44  434 (16.3) 340 (6.6) 209 (4.2) 189 (3.7) 472 (9.5) 405 (7.9) 
45-54  406 (15.2) 400 (6.4) 195 (3.7) 181 (2.9) 494 (9.3) 534 (8.5) 
55-64  249 (9.3) 255 (5.5) 127 (3.4) 137 (2.9) 316 (8.6) 343 (7.3) 
65+  243 (9.1) 253 (7.1) 158 (6.7) 172 (4.8) 228 (9.7) 246 (6.9) 
Living Status n (%)       
Homeless  162 (13.6) 87 (11.3) 90 (7.5) 46 (6.0) 178 (14.9) 91 (11.9) 
Alone  866 (9.1) 594 (6.4) 405 (4.3) 311 (3.4) 987 (10.4) 741 (8.0) 
With Others  1639 (10.0) 1216 (6.8) 827 (5.3) 667 (3.7) 1898 (11.6) 1493 (8.4) 
Marital Status n (%)       
Never married 1946 (11.0) 959 (7.6) 978 (5.5) 520 (4.1) 2212 (12.5) 1167 (9.3) 
Married or SO 433 (8.1) 524 (6.1) 241 (4.5) 274 (3.2) 492 (9.2) 653 (7.6) 
Widowed or Separated 288 (7.2) 414 (6.1) 148 (3.7) 230 (3.4) 359 (9.0) 505 (7.5) 
Education n (%)       
< High School 720 (10.6) 436 (7.6) 376 (5.6) 234 (4.1) 820 (12.1) 526 (9.2) 
High School 756 (9.4) 503 (6.6) 380 (4.7) 277 (3.6) 922 (11.5) 646 (8.5) 
> High School 1191 (9.7) 958 (6.6) 611 (5.0) 513 (3.5) 1321 (10.8) 1153 (7.9) 
Employment n (%)       
Unemployed 1769 (10.4) 1220 (7.3) 919 (5.4) 644 (3.9) 2000 (11.7) 1485 (8.9) 
Employed 379 (8.0) 270 (5.4) 178 (3.7) 139 (2.8) 465 (9.8) 346 (7.0) 
Other 519 (9.9) 407 (6.5) 270 (5.1) 241 (3.8) 598 (11.4) 494 (7.9) 






























Substance Use  220 (7.4) 122 (6.7) 118 (4.0) 55 (3.0) 256 (8.6) 154 (8.5) 
Schizophrenia  1307 (8.1) 686 (8.8) 660 (6.0) 376 (4.8) 1511 (13.8) 810 (10.3) 
Mood Disorders  751 (7.5) 780 (5.6) 357 (3.6) 390 (2.8) 899 (9.0) 1021 (7.3) 
Anxiety Disorder  41 (5.1) 44 (4.0) 14 (1.7) 28 (2.6) 53 (6.6.) 62 (5.7) 
Personality Disorder  35 (8.3) 55 (4.8) 22 (5.2) 29 (2.5) 43 (10.2) 78 (6.8) 
Neurocognitive Disorders 166 (23.1) 111 (16.1) 122 (17.0) 81 (11.8) 137 (19.1) 95 (13.8) 
Neurodevelopmental Disorders 76 (21.1) 36 (17.8) 40 (11.1) 25 (12.4) 85 (23.6) 33 (16.3) 
Other 57 (7.9) 54 (5.4) 25 (3.5) 34 (3.4) 67 (9.3) 65 (6.5) 
Note: *Primary diagnoses applied at discharge 
 




Table 6 Proportion of CI Use Among Adult Mental Health First-Admission Inpatients by Gender and RAI-MH Scales 













Cognitive Performance Scale n (%)       
0-2 2159 (8.6) 1453 (5.6) 1036 (4.1) 734 (2.8) 2529 (10.1) 1865 (7.2) 
3-4 273 (22.3) 250 (18.0) 162 (13.3) 154 (11.1) 303 (24.8) 269 (19.4) 
5-6 235 (34.5) 194 (30.6) 169 (24.8) 136 (21.5) 231 (33.9) 191 (30.1) 
Depression Severity Index n (%)       
0-2 1395 (10.3) 780 (7.0) 740 (5.5) 438 (3.9) 1478 (10.9) 889 (8.0) 
3-8 780 (7.0) 908 (7.4) 526 (5.0) 480 (3.9) 1341 (12.8) 1144 (9.4) 
9-15 195 (6.5) 209 (4.5) 101 (3.3) 106 (2.3) 244 (8.1) 292 (6.3) 
Mania n (%)       
0-2 692 (4.2) 474 (2.8) 325 (2.0) 234 (1.4) 973 (5.9) 769 (4.5) 
3-5 515 (10.8) 331 (6.7) 273 (5.8) 183 (3.7) 581 (12.2) 410 (8.4) 
6-20 1460 (24.7) 1092 (18.0) 769 (13.0) 607 (10.0) 1209 (25.5) 1146 (18.9) 
Positive Symptoms Scale n (%)       
0-2 854 (5.6) 682 (3.9) 420 (2.8) 343 (2.0) 1058 (7.0) 939 (5.4) 
3-6 1197 (13.9) 805 (10.3) 635 (7.4) 440 (5.6) 1308 (15.2) 958 (12.3) 
7-12 616 (18.5) 410 (15.5) 312 (9.4) 241 (9.1) 697 (21.0) 428 (16.2) 
Risk of Harm to Others Scale n (%)       
0-2 719 (4.0) 610 (3.0) 290 (1.7) 274 (1.3) 1077 (6.1) 994 (4.8) 
3-4 618 (12.6) 536 (12.0) 299 (6.1) 288 (6.5) 699 (14.3) 592 (13.3) 
5-6 1330 (29.1) 751 (26.8) 778 (17.0) 462 (16.5) 1287 (28.2) 739 (26.4) 
Severity of Self Harm Scale n (%)       
0-2 1747 (10.9) 1112 (7.4) 871 (5.4) 584 (3.9) 1898 (11.9) 1290 (8.5) 
3-4 476 (11.0) 410 (8.4) 274 (6.3) 252 (5.2) 587 (13.5) 464 (9.5) 
5-6 444 (6.6) 375 (4.7) 222 (3.3) 188 (2.4) 578 (8.6) 571 (7.2) 
Note: A description of RHO and SOS scales can be found in Appendix A, Table 10 
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Table 7 Proportion of CI Use Among Adult Mental Health First-Admission Inpatients by Gender and CAPs 













Traumatic Life Events CAP       
0  2439 (10.1) 1589 (7.0) 1250 (5.2) 845 (3.7) 2769 (11.4) 1879 (8.3) 
1 114 (6.5) 132 (4.9) 58 (3.3) 79 (2.9) 160 (9.1) 221 (8.2) 
2 114 (10.4) 176 (7.2) 59 (5.4) 100 (4.1) 134 (12.2) 225 (9.2) 
Social Relationships CAP       
0  1019 (8.0) 660 (5.1) 507 (4.0) 348 (2.7) 1176 (9.2) 845 (6.6) 
1 915 (12.5) 696 (9.1) 464 (6.4) 371 (4.9) 1038 (14.2) 817 (10.7) 
2 733 (10.6) 541 (7.3) 396 (5.7) 305 (4.1) 849 (12.2) 663 (9.0) 
Interpersonal Conflict CAP       
0  730 (4.4) 551 (3.1) 295 (1.8) 257 (1.5) 1093 (6.6) 885 (5.0) 
1 1061 (15.0) 697 (10.1) 561 (8.0) 275 (5.4) 1131 (16.0) 781 (11.3) 
2 876 (25.5) 649 (18.9) 511 (14.9) 392 (11.4) 839 (24.5) 659 (19.2) 
Criminal Activity CAP       
0 1020 (6.2) 1090 (5.1) 514 (3.2) 592 (2.8) 1241 (7.6) 1398 (6.5) 
1 1647 (15.4) 807 (12.3) 853 (8.0) 432 (6.6) 1822 (17.0) 927 (14.2) 
Substance Use CAP       
0  1157 (9.1) 1127 (6.6) 600 (4.7) 632 (3.7) 1304 (10.3) 1324 (7.7) 
1 137 (8.5) 72 (6.6) 62 (3.9) 39 (3.6) 169 (10.5) 86 (7.8) 
2 1373 (10.8) 698 (7.2) 705 (5.5) 353 (3.6) 1590 (12.5) 915 (9.4) 
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Figure 4  Use of CIs among adults at First-Admission to inpatient Psychiatry in Ontario, Full RHO, 
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Figure 5 A Comparison of CPS Scores >3 and RHO Scores >3 among adults at First-Admission to Inpatient Psychiatry in Ontario, by 
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3.3. Logistic Regression Analysis Findings  
A gender-stratified multivariable logistic regression was performed to understand which 
variables are associated with experience of any control interventions (CI). Modelling results are 
summarized in Tables 8 and 9. A summary of adjusted odd ratios can be found in Figure 6. 
 
3.3.1. Control Interventions: Women 
Table 8 summarizes the results of the multivariable logistic regression among women, 
modelling for experiencing any CI. Among demographic characteristics: age, living status and 
marital status were statistically significant and associated with lower odds of experiencing 
restraint/confinement. The odds of experiencing a CI were slightly decreased by marital status 
and were more substantially influenced by age (lowered odds of 24%) and living status (lowered 
odds between 40-44%).  
Most diagnoses were not significant, however among significant variables, having a 
primary diagnosis of either a neurocognitive or neurodevelopmental disorder more than doubled 
the odds of experiencing a CI among women. 
When examining behavioural characteristics, posing a risk of harm to others, wandering 
and elopement were all significant associated with CIs. A moderate or severe score on the RHO 
scale, generated a 2.3- and 5.1-times greater odds of experiencing a CI among women, 
respectively. Subsequently, higher incidence of elopement and/or elopement attempts increased 
the odds of experiencing CIs by 1.9 times, at the lowest level of elopement, and 2.7 times at the 
highest level. In general, the odds of CI intensified as the frequency and/or severity of the 
behaviours increased. However, the greatest odds of experiencing CI were with a moderate level 
rather than the highest level of elopement. Wandering also doubled the odds of experiencing CIs 
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regardless if wandering behaviours were exhibited daily or less frequently. However, the lowest 
level of wandering was not significantly associated with CIs. 
The only clinical symptom associated with the experience of CIs  for women was 
hallucinations, which was associated with 1.3 greater odds of CI. With regard to substance use, 
only recent use of stimulants was significantly associated, with an odds ratio of 1.5. Higher 
scores on the mania scale were associated with incrementally higher odds of experiencing a CI. 
A mania scale score between 6-20 tripled the odds of being restrained and/or confined. 
Among women, triggering the Interpersonal Conflict CAP was significantly associated 
with CIs. The odds of experiencing a CI were 2 times greater when at high risk for interpersonal 
conflict. This model for CI among women was assessed as a very good fit based on the c-statistic 
equal to 0.82. The model was evaluated using full uncategorized RAI-MH scales as well and 
there was only a 0.01 increase to the final c-statistic (0.83), as such collapsed scales were 
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Table 8 Multivariable Logistic Regression Model: Analysis of CI Use among Women in Inpatient Psychiatry, Ontario 2006-2018 (n=27944) 
 Block 1 (C-stat = 0.553) Block 2 (C-stat = 0.606) Block 3 (C-stat = 0.811) Block 4 (C-stat = 0.824) Final Model (C-stat = 0.822) 
 Odds Ratio  
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 




Age           
18-24 (REF) 1.00  1.00  1.00  1.00  1.00  
25-34  0.99 (0.84-1.17) 0.93  0.89 (0.76-1.06) 0.19 0.92 (0.77-1.10) 0.37 0.92 (0.77-1.10) 0.37 0.92 (0.77-1.10) 0.37 
35-44  0.89 (0.75-1.05) 0.17  0.78 (0.75-1.05) 0.005 0.78 (0.65-0.94) 0.0098 0.80 (0.67-0.96) 0.017 0.80 (0.67-0.96) 0.012 
45-54  0.88 (0.74-1.05) 0.16  0.75 (0.63-1.90) 0.0016 0.77 (0.64-0.91) 0.0046 0.79 (0.66-0.95) 0.011 0.79 (0.66-0.95) 0.0068 
55-64  0.76 (0.63-0.92) 0.0006 0.62 (0.51-0.76) <.0001 0.64 (0.53-0.78) <.0001 0.67 (0.54-0.87) <.0001 0.67 (0.54-0.87) <.0001 
65+  1.04 (0.85-1.27) 0.72 0.73 (0.59-0.90) 0.0029 0.69 (0.56-0.84) 0.0007 0.70 (0.56-0.87) 0.0012 0.70 (0.56-0.87) 0.0007 
Living Status           
Homeless (REF) 1.00  1.00  1.00      
Alone  0.56 (0.44-0.71) <.0001 0.60 (0.47-0.76) <.0001 0.77 (0.59-1.01) 0.051     
With Others  0.60 (0.48-0.76) <.0001 0.63 (0.50-0.80) 0.0001 0.79 (0.61-1.02) 0.068     
Marital Status            
Never married (REF) 1.00  1.00        
Married / Partnered 0.81 (0.72-0.92) 0.0014 0.92 (0.81-1.05) 0.20       
Widowed or Separated 0.85 (0.74-0.97) 0.0155 0.90 (0.79-1.04) 0.15       
           
DIAGNOSES           
Primary Diagnosis           
Substance Use    0.80 (0.43-1.49) 0.48       
Schizophrenia    1.14 (0.63-2.07) 0.67       
Mood Disorder   0.71 (0.39-1.29) 0.25       
Anxiety Disorder    0.48 (0.25-0.94) 0.032 0.87 (0.63-1.21) 0.406     
Personality Disorder    0.53 (0.28-1.02) 0.056       
Neurocognitive Disorder   2.59 (1.39-4.83) 0.0028 1.98 (1.53-2.56) <.0001 1.94 (1.70-2.58) <.0001 1.94 (1.70-2.58) <.0001 
Neurodevelopmental Disorder   2.35 (1.17-4.72) 0.015 1.75 (1.16-2.65) 0.0079 1.80 (1.16-2.65) 0.0026 1.80 (1.16-2.65) 0.0059 
Other Disorder   0.64 (0.34-1.24) 0.19       
           
BEHAVIOURAL CHARACTERISTICS 
RAI-MH Scales           
Risk of Harm to Others Scale           
0-2 (REF)     1.00  1.00  1.00  
3-4     2.28 (2.00-2.63) <.0001 1.94 (1.69-2.24) <.0001 2.30 (2.00-2.63) <.0001 
5-6     5.08 (4.44-5.80) <.0001 3.91 (3.37-4.52) <.0001 5.12 (4.47-5.84) <.0001 
Severity of Self-Harm Scale           
0-2 (REF)     1.00  1.00    
3-4     1.05 (0.92-1.19) 0.49 1.05 (0.92-1.19) 0.46   
5-6     0.87 (0.76-0.99) 0.031 0.90 (0.76-0.99) 0.13   
Mania Scale           
0-2 (REF)     1.00  1.00  1.00  
3-5     1.68 (1.44-1.95) <.0001 1.46 (1.22-1.68) <.0001 1.68 (1.44-1.95) <.0001 
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Individual Behaviours 
Elopement           
0 (REF)     1.00  1.00  1.00  
1     1.90 (1.43-2.50) <.0001 1.77 (1.34-2.34) <.0001 1.90 (1.44-2.50) <.0001 
2     2.71 (2.30-3.20) <.0001 2.43 (2.06-2.87) <.0001 2.71 (2.30-3.20) <.0001 
3     2.60 (2.04-3.31) <.0001 2.44 (1.91-3.11) <.0001 2.60 (2.04-3.31) <.0001 
Wandering           
0 (REF)     1.00  1.00  1.00  
1     1.32 (1.96-1.81) 0.089 1.32 (1.96-1.81) 0.0149 1.32 (1.96-1.81) 0.15 
2     1.92 (1.62-2.27) <.0001 1.92 (1.62-2.27) <.0001 1.92 (1.62-2.27) <.0001 
3     2.06 (1.71-2.47) <.0001 2.06 (1.71-2.47) <.0001 2.06 (1.71-2.47) <.0001 
           
CLINICAL CHARACTERISTICS 
Individual Symptoms           
Involuntary Admission        1.01 (0.89-1.16) 0.85   
Hallucinations        1.34 (1.17-1.53) <.0001 1.33 (1.18-1.49) <.0001 
Command Hallucinations        0.86 (0.70-1.05) 0.13   
Delusions        0.99 (0.87-1.13) 0.93   
Abnormal Thoughts        1.12 (0.98-1.27) 0.099   
Substance Use            
Recent Inhalant Use       0.97 (0.48-1.93) 0.93   
Recent Hallucinogens       1.15 (0.73-1.82) 0.55   
Recent Cocaine       1.04 (0.81-1.35) 0.69   
Recent Stimulants       1.48 (1.11-1.96) 0.0076 1.37 (1.07-1.76) 0.012 
Recent Opiates       0.77 (0.58-1.03) 0.074   
Recent Cannabis       0.99 (0.84-1.19) 0.83   
Problematic Alcohol Use       0.99 (0.81-1.22) 0.99   
Smoking       0.94 (0.84-1.06) 0.33   
Misuse of Medications       1.04 (0.86-1.26) 0.68   
Withdrawal       0.96 (0.78-1.19) 0.80   
Clinical Assessment Protocols 
(CAPs) 
          
Traumatic Life Events CAP           
0 (REF)       1.00  1.00  
1       0.78 (0.64-0.95) 0.013 0.76 (0.62-0.92) 0.0058 
2       0.80 (0.67-0.96) 0.018 0.80 (0.66-0.95) 0.012 
Social Relationships CAP           
0 (REF)       1.00    
1       1.09 (0.96-1.24) 0.18   
2       0.93 (0.81-1.07) 0.27   
Interpersonal Conflict CAP           
0 (REF)       1.00  1.00  
1       1.53 (1.34-1.75) <.0001 1.54 (1.34-1.75) <.0001 
2       2.04 (1.74-2.38) <.0001 2.07 (1.74-2.38) <.0001 
Criminal Activity CAP           
0(REF)       1.00    
1       1.12 (0.96-1.24) 0.062   
Substance Use CAP           
0 (REF)       1.00    
1       0.99 (0.76-1.31) 0.98   
2       0.99 (0.81-1.21) 0.93   
Note: Highlighted = removed from model *CI = Confidence interval in this table 
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3.3.2. Control Interventions: Men 
Table 9 summarizes the results of the multivariable logistic regression among men, 
modelling for any CI. All age groups, any non-homeless living status and marital status were 
significantly associated with lower odds of experiencing CIs among men. The odds of 
experiencing a CI were decreased between 38-50% for in the middle age groups and more 
modestly for those in the youngest age group (33% reduction in odds) and the lowest for those in 
the oldest age group (only a 26% reduction). Both living alone, or living with others, was 
associated with decreased odds of CI by 30%.  
Most diagnoses were not significant, however among significant variables, having a 
primary diagnosis of substance use disorder, or anxiety disorder, was associated with decreased 
odds of experiencing CI by 49% and 66%, respectively. A mood disorder diagnosis also reduced 
the odds of being restrained/confined by 66%. While having a neurocognitive disorder was 
associated with 2.4 times greater odds of experiencing a CI. There were more clinical symptoms 
associated with CIs for men than for women. Involuntary admission and presence of abnormal 
thoughts increased the odds of CIs by 13% and 28%, respectively. With regard to substance use, 
both the recent use of stimulants and smoking were significantly associated with CIs, with 
stimulant generating 1.4 times greater odds of having a CI administered. Smoking, on the other 
hand, was associated with 13% decreased odds of restraint/confinement. Higher scores on the 
Mania scale were associated with incrementally higher odds of experiencing a CI. A Mania scale 
score between 6-18 tripled the odds of being restrained and/or confined. 
When examining behavioural characteristics, the risk of harm to others, wandering and 
elopement were all significant associated with CIs. With a moderate or severe score on the RHO 
scale, there was a 1.5- and 3.2- times greater odds of experiencing a CI, respectively. 
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Subsequently, elopement and/or elopement attempts significantly increased the odds of 
experiencing CIs by 2.4 times, at the lowest level of elopement and 1.5 times. In general, the 
odds of CI intensified as the frequency and/or severity of the behaviours increased. Wandering 
also increased the odds of experiencing CIs by at least 1.5 times. However, the lowest level of 
wandering was not significantly associated with CIs.  
Among men, triggering any CAP, with the exception of substance use, was associated 
with CIs. Triggering the Trauma and Social Relationships CAPs was shown to be protective 
against experiencing a CI.  Having history of trauma or having ongoing safety needs related to a 
trauma was associated with 18% lowered odds of CIs and having serious social relationship 
issues like isolation of family dysfunction reduced the odds of CIs by 16%.  However, only 
moderate trauma levels and safety needs and severe isolation/family dysfunction were 
significant. In contrast, interpersonal conflict and previous criminal involvement were associated 
with odds ratios of 2.3 and 1.3, respectively. This model for CI among men was assessed as a 
very good fit based on the c-statistic equal to 0.82. The model was also evaluated using full 
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Table 9 Multivariable Logistic Regression Model: Analysis of CI Use among Men in Inpatient Psychiatry, Ontario 2006-2018 (n=27069) 
 Block 1 (C-stat = 0.584) Block 2 (C-stat = 0.627) Block 3 (C-stat = 0.811) Block 4 (C-stat = 0.817) Final Model (C-stat = 0.817) 
 Odds Ratio  
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 
𝜌-value Odds Ratio 
(95% CI*) 




Age           
18-24 (REF) 1.00   1.00   1.00   1.00   1.00   
25-34  0.77 (0.69-0.87) <.0001 0.76 (0.67-0.85) <.0001 0.91 (0.76-1.10) 0.32 0.84 (0.74-0.95) 0.0072 0.84 (0.74-0.95) 0.0072 
35-44  0.62 (0.54-0.71) <.0001 0.61 (0.54-0.70) <.0001 0.78 (0.64-0.94) 0.0089 0.76 (0.64-0.87) 0.0002 0.76 (0.64-0.87) 0.0002 
45-54  0.56 (0.48-0.64) <.0001 0.54 (0.47-0.62) <.0001 0.77 (0.64-0.93) 0.0059 0.73 (0.63-0.85) <.0001 0.73 (0.63-0.85) <.0001 
55-64  0.50 (0.42-0.59) <.0001 0.46 (0.39-0.55) <.0001 0.65 (0.52-0.80) <.0001 0.60 (0.50-0.71) <.0001 0.60 (0.50-0.71) <.0001 
65+  0.84 (0.70-0.99) 0.049 0.58 (0.47-0.70) <.0001 0.69 (0.55-0.87) 0.0016 0.70 (0.57-0.86) 0.0005 0.70 (0.57-0.86) 0.0005 
Living Status           
Homeless (REF) 1.00  1.00  1.00      
Alone  0.70 (0.58-0.83) <.0001 0.94 (0.83-1.07) 0.34 1.02 (0.88-1.17) 0.34     
With Others  0.70 (0.59-0.83) <.0001 0.85 (0.73-0.98) 0.025 1.00 (0.87-1.16) 0.025     
Marital Status            
Never married (REF) 1.00  1.00  1.00      
Married / Partnered 0.83 (0.73-0.94) 0.0031 0.72 (0.60-0.98) 0.0004 0.78 (0.60-1.01) 0.062     
Widowed or Separated 0.76 (0.67-0.88) 0.0001 0.68 (0.57-0.86) <.0001 0.80 (0.57-1.03) 0.086     
           
DIAGNOSES           
Primary Diagnosis           
Substance Use    0.51 (0.29-0.89) 0.018 1.11 (0.89-1.38) 0.36     
Schizophrenia    0.82 (0.47-1.42) 0.47       
Mood Disorder   0.56 (0.32-0.97) 0.037 0.96 (0.88-1.10) 0.79     
Anxiety Disorder    0.34 (0.18-0.65) 0.0009 0.86 (0.62-1.20) 0.39     
Personality Disorder    0.54 (0.28-1.03) 0.062       
Neurocognitive Disorder   2.43 (1.36-4.34) 0.0026 1.95 (1.50-2.54) <.0001 2.13 (1.70-2.69) <.0001 2.14 (1.70-2.70) <.0001 
Neurodevelopmental Disorder   1.49 (0.81-2.73) 0.20       
Other Disorder   0.57 (0.31-1.05) 0.73       
           
 
RAI-MH Scales           
Risk of Harm to Others Scale           
0-2 (REF)     1.00  1.00  1.00  
3-4     2.29 (1.99-2.62) <.0001 1.15 (1.33-1.72) <.0001 1.52 (1.34-1.73) <.0001 
5-6     5.13 (4.48-5.87) <.0001 3.13 (2.77-3.53) <.0001 3.16 (2.79-3.57) <.0001 
Severity of Self-Harm Scale           
0-2 (REF)     1.00      
3-4     1.05 (0.92-1.19) 0.028     
5-6     0.86 (0.76-0.98) 0.500     
Mania Scale           
0-2 (REF)           
3-5     1.00  1.00  1.00  





    2.71 (2.30-3.19) <.0001 2.35 (2.08-2.65) <.0001 2.36 (2.09-2.66) <.0001 
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Individual Behaviours 
Elopement           
0 (REF)     1.00  1.00  1.00  
1     1.31 (0.96-1.80) 0.091 1.55 (1.20-1.99) 0.0007 1.54 (1.20-1.99) 0.0007 
2     1.92 (1.63-2.28) <.0001 2.40 (2.07-2.78) <.0001 2.41 (2.08-2.79) <.0001 
3     2.07 (1.72-2.49) <.0001 2.41 (1.92-3.04) <.0001 2.42 (1.92-3.04) <.0001 
Wandering           
0 (REF)     1.00  1.00  1.00  
1     1.31 (0.96-1.80) 0.091 1.19 (0.90-1.58) 0.2213 1.20 (0.91-1.59) 0.2213 
2     1.92 (1.63-2.28) <.0001 1.66 (1.43-1.76) <.0001 1.67 (1.43-1.77) <.0001 
3     2.07 (1.72-2.49) <.0001 1.48(1.24-1.76) <.0001 1.49 (1.25-1.77) <.0001 
           
 
Individual Symptoms           
Involuntary Admission        1.13 (1.01-1.26) 0.037 1.13 (1.01-1.26) 0.037 
Hallucinations        1.05 (0.93-1.17) 0.44   
Command Hallucinations        1.12 (0.96-1.32) 0.16   
Delusions        1.01 (0.89-1.12) 0.89   
Abnormal Thoughts        1.29 (1.16-1.44) <.0001 1.32 (1.19-1.46) <.0001 
Substance Use            
Recent Inhalant Use       0.71 (0.46-1.14) 0.15   
Recent Hallucinogens       1.19 (0.89-1.62) 0.27   
Recent Cocaine       1.06 (0.88-1.26) 0.53   
Recent Stimulants       1.30 (1.13-1.70) 0.0012 1.39 (1.16-1.46) 0.0012 
Recent Opiates       0.86 (0.68-1.07) 0.19   
Recent Cannabis       1.08 (0.92-1.21) 0.30   
Problematic Alcohol Use       1.06 (0.92-1.24) 0.44   
Smoking       0.87 (0.79-0.96) 0.0056 0.87 (0.79-0.95) 0.0056 
Misuse of Medications       0.99 (0.85-1.16) 0.78   
Withdrawal       0.96 (0.82-1.13) 0.62   
Clinical Assessment Protocols 
(CAPs) 
          
Traumatic Life Events CAP           
0 (REF)       1.00  1.00  
1       0.72 (1.58-0.88) 0.0018 0.71 (0.58-0.88) 0.0013 
2       0.83 (0.66-1.03) 0.90 0.82 (0.66-1.03) 0.083 
Social Relationships CAP           
0 (REF)       1.00  1.00  
1       0.95 (0.84-1.05) 0.30 0.94 (0.84-1.05) 0.30 
2       0.84 (0.76-0.94) 0.0023 0.84 (0.76-0.94) 0.0023 
Interpersonal Conflict CAP           
0 (REF)       1.00  1.00  
1       1.76 (1.57-1.97) <.0001 1.76 (1.57-1.97) <.0001 
2       2.31 (2.02-2.65) <.0001 2.31 (2.02-2.65) <.0001 
Criminal Activity CAP           
0(REF)       1.00  1.00  
1       1.27 (1.14-1.40) <.0001 1.27 (1.14-1.40) <.0001 
Substance Use CAP           
0 (REF)       1.00    
1       0.92 (0.75-1.13) 0.43   
2       0.92 (0.79-1.08) 0.31   
Note: Highlighted = removed from model *CI = Confidence interval in this table  
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Figure 6 Adjusted Odds Ratios for Clinical Characteristics Significantly Associated with 
the Odds of Control Interventions by Gender 
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4.0 Discussion 
The objective of this study was to understand gender differences (GDs) in control 
interventions (CIs) at first admission to acute inpatient psychiatric settings across Ontario. The 
analysis of the OHMRS data found that: (1) the use of CIs has remained steady overtime with 
more men experiencing CIs than women, (2) while there are similarities in the demographic, 
behavioral and clinical variables associated with CI use, some notable GDs were identified in 
analysis. This section will cover these findings as well as discuss implications for practice and 
future research as well as the limitations of this study. 
 
4.1 Gender Differences in Control Interventions Over Time 
Both restraint and confinement rates remained steady over time, hovering around 10%, 
with CI rates 3% higher among men, compared to women. This GD is relatively small and is best 
explained by higher rates of violence, aggression and disruptive behaviour among men. The 
prevalence of high risk of harm to others over time, displays a widening gender gap, with men 
exhibiting increasing rates of high risk of harm to others (See Figure 5). When examining 
prevalence of CI for those with a violence and aggression, the GD decreases, suggesting that 
those posing high safety risks are at greater odds of restraint. An alternative explanation is that 
men may experience conditions of altered cognition more often than women. For example, 12% 
more men were diagnosed with schizophrenia and 2.1% more men are stimulate users, both of 
which were significantly associated CI use. Cognitive impairment, as determined by in-hospital 
assessments, is associated with CIs (Yevchak et al., 2015) and higher rates of impaired cognition 
could explain higher rates of CIs among men. Applied behaviour management strategies may be 
difficult to implement with cognitively impaired patients as effective communication may be a 
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challenge between patient and provider (Emmanuel et al., 2013; Ll et al., 2015). Instead, 
consultation with specialists in neurocognitive disorders may be important for contexts such as 
acute psychiatry.  However, rates of neurocognitive disorders were similar between men and 
women and prevalence of elevated CPS scores actually decreased over time for genders (Figure 
5). Thus, violent and aggressive behaviours better explain the gendered CI discrepancy over time 
rather than cognition. 
Among patients at risk of harm to themselves, more men experienced CIs than women. 
However, the overall proportion of CIs was lower for this group compared to those at risk of 
harm to others. Lower proportions CIs among this group is positive, as use of CIs to manage 
self-harm behaviours may exacerbate trauma and negative emotions as well as impair the 
therapeutic relationship between the staff and their patients (Emmanuel et al., 2013). Likewise, 
the odds of CI were lower for men and women with a history of trauma compared to those 
without trauma. The traumatic life events CAP, considers a wide range of events that may be 
traumatic for patients, ranging from living in areas of conflict to witnessing an accident. This 
finding is encouraging and consistent with the “trauma-informed care” approach to restraints, 
which suggest that those with traumatic pasts may suffer more adverse effects with the 
application of a restraint, and thus staff should find safety alternatives (Emmanuel et al., 2013).  
On a similar note, this analysis revealed that confinement was used more often than 
restraints for both genders. Confinement is sometimes used as an alternative to restraint for 
patients exhibiting frequent aggressive behaviours, as applying restraints may increase risk of 
injury to staff and patients. However, isolation may also increase risk of suicidal ideation, self-
harm behaviours and depressive symptoms (Emmanuel et al., 2013; Ll et al., 2015). Therefore, 
patients at high risk of self-harm behaviours benefit from alternatives to CIs altogether.  
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Overall, the rate of restraints over time has remained steady for both genders with slightly 
more men experiencing CIs. Considering that rates of cognitive impairment have declined, the 
difference between CI use between the genders is better explained by violent/aggressive 
behaviours have remained consistently higher (20%) among men over time. Lastly, at-risk 
populations such as those at risk of self-harm and those with a history of trauma are 
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4.2 Gender Differences in the Proportion of Control Intervention  
The overall proportion of patients who experienced CIs for both genders remained under 
12% of the total population of adult psychiatric inpatients at first admission in acute psychiatry 
units. The percentage of men experiencing use of CIs was higher than women, even when 
holding violent/aggressive behaviours constant. When considering demographic characteristics, 
the effect of age is likely a confounding factor for certain behaviours and diagnoses. For 
example, older age increases the likelihood of a patient having neurocognitive disorders, such as 
dementia (Derreberry & Holroyd, 2019), thus, having a higher proportion patients restrained in 
older age groups would be plausible due to a higher frequency cognitive impairment. As 
previously mentioned, age and also be considered through its association with diagnoses and 
behaviour. In comparison to older age groups, younger age is associated with schizophrenia-
spectrum disorders or stimulant use (Immonen, Jääskeläinen, Korpela, & Miettunen, 2017; Sara 
et al., 2012) and may have contributed to slightly elevated CI use among this age group. Since 
age was found to be protective against the odds of experiencing CI, behavioural and diagnostic 
variables better explain differences in CI use across the lifespan. 
Clinical symptoms associated with specific diagnoses may also produce behaviours 
associated with CIs. For example, disorganized and excited-type psychiatric symptoms are 
predictive of aggression (Podubinski, Lee, Hollander, & Daffern, 2017), which may explain in 
part why higher proportions of patients with schizophrenia-spectrum disorders experience CIs, 
even among women, who generally experience CIs less often. CIs are applied in higher 
proportions to men for most diagnoses, with some exceptions. However, the only diagnoses 
significantly associated with the odds of CIs were neurocognitive and neurodevelopmental 
disorders. Therefore, according to this analysis, behaviours and individual clinical symptoms 
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were more strongly associated with the odds of restraint and/or confinement.   
The only substance associated with CIs for both men and women was stimulant use, 
which includes amphetamines or methamphetamines. This relationship may be attributable to the 
psychiatric complaints, common to stimulant users, such as delusions, paranoia, hallucinations, 
and suicidal ideation (Center for Substance Abuse Treatment, 1999). Similarly, one GD is that 
hallucinations were significant among women, while for men, abnormal thoughts were 
significant for CI use. This difference may be attributable to men exhibiting more delusional 
thought processes both at onset and longitudinally (Yevchak et al., 2015). Interestingly, 
command hallucinations were not associated with CIs for either gender. These hallucinations 
may involve thoughts commanding the person to harm others, so it comes as a surprise that they 
do not seem to be associated with CIs. This non-significant finding could be explained by the 
fact that command hallucinations are rare and may occur often enough to influence CI use. 
Behaviours and clinical characteristics were the most strongly associated with the odds of 
CI and exhibited interesting GDs. For example, the Criminal Activity CAP was associated with 
greater odds of CI for men but was not significant for women. When this CAP is triggered it 
identifies those with both violent and non-violent actions requiring police intervention in the past 
year. It is interesting that this CAP has no effect on the odds for women, possibly because 
women were less likely to have prior criminal involvement. Among variables significant in both 
gender models, the magnitude of the effect varied between genders. The most interesting gender 
effect is likely in the risk of harm to others scale. While women were at lower odds of 
experiencing CI for many variables, at the highest levels of the RHO, women were at 5 times 
greater odds of experiencing CI, compared to men who were only at 3 times greater odds at the 
same level (See Figure 6). This is consistent with findings of CI use among the forensic 
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population, which also found that women at the highest levels of aggression were more likely to 
experience CIs (Mathias, 2014). It is possible that when women exhibit this level of violence and 
aggression, staff may feel that they are unable to manage without restraints, as these behaviours 
are uncommon and unexpected among women. It is also likely that women with lower scores on 
the RHO were less likely to experience a CI compared to men with lower scores on the RHO. 
Therefore, the odds of CI increase more at higher levels of risk for women than men. Staff 
reactions to risk of harm may also vary by gender as staff take into consideration the acute threat, 
past experiences working with aggressive patients and the information they have the patient 
(Riahi, Thomson, & Duxbury, 2020). While there seems to be a gender effect based on this 
finding, the decision to use CIs requires immediate response making it difficult to consider 
alterative options. However, while the decision to use CIs is deemed as a “last resort” there is 
little research on understanding what constitutes a “last resort” (Riahi et al., 2020). While men 
may be perceived as threats more often by staff, due to their attributes and/or behaviours, staff 
perceptions also play a significant role in the decision to use or prevent CIs. Similarly, the odds 
of CI for men with interpersonal conflict, compared to those without, was 30% more compared 
to the odds for women exhibiting conflict, compared to women without. At this level of 
interpersonal conflict, a patient is experiencing conflict with everyone around them, not only 
friends and family. This pattern is also exhibited for manic symptoms, despite men and women 
having proportionally equal levels of mania in this acute psychiatric population. One explanation 
could be that the combination of behaviours exhibited may be, collectively, perceived as a 
greater theat. For example, creating conflict through verbal and physical abuse may be viewed as 
a greater threat than resisting care and being socially disruptive.  
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While men appeared to experience more CIs, there was evidence of best practices in CI 
use for at-risk populations. When examining CAPs, the odds ratio for men with trauma 
appropriately decreased the odds of experiencing a CI. This finding is encouraging and 
consistent with the a “trauma informed care” approach to restraints, which suggest that those 
with traumatic pasts may suffer more adverse effects with the application of a 
restraints/confinement, and thus staff should find safety alternatives (Emmanuel et al., 2013). 
Smoking and dysfunctional social relationships were also among protective factors against the 
use of CIs for men. However, these variables are likely confounding for other behavioural and 
clinical variables. For example, smokers are likely more stable, if they are able to leave the unit 
to smoke and are thus, not exhibiting behaviours that merit CIs. Similarly, patients with the 
social dysfunction (Social Relationships CAP) are experiencing a crumbling support system and 
may be exhibiting social withdrawal, as family and friends may feel overwhelmed by their 
condition. These conditions typically not associated with CIs, as these patients are more subdued. 
In summary, behavioural and clinical variables were more strongly associated with the 
odds of experiencing CIs than diagnoses or demographic variables for both men and women. 
Trauma and self-harm behaviours were protective against CI use for both genders. Some 
interesting findings were that men were at a greater odd of experiencing CI for most variables, 
even at similar levels of conflict with others or mania symptoms, with the exception of 
hallucinations and the highest level of violence and aggression. Overall, violent/aggressive 
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5.0 Implications 
5.1 Clinical Practice 
Behaviours and clinical symptoms, as assessed by the CAPs and scales, were the most 
strongly associated with CIs. This study demonstrates that these clinical tools are effective in 
identifying patients at a greater of odds of CIs and thus, have the potential to be used in care 
planning. While the RAI-MH assessment is mandated, it is not compulsory to apply the findings 
of some assessment tools in treatment of inpatients. For example, the CAPs are not mandated in 
clinical care, but provide useful information about the patients support status, relationships, 
behavioural challenges and symptoms. Using these tools to identify at-risk patients could support 
early stabilization and planning to prevent use of CIs (Emmanuel et al., 2013). Providing staff 
with adequate training in to incorporate these tools into behaviour management will support 
least-restraint approaches, continue to reduce CI use and improve patient outcomes. In particular, 
men may benefit from early behavior management strategies as indicated by indicators such as 
involuntary admission and interpersonal conflict measures; establishing rapport with staff, for 
example, may reduce the risk of restraint during the hospital stay. Research shows that if staff 
understand the adverse effects of CIs this translates into more empathetic treatment (Khalil, Al 
Ghamdi, & Al Malki, 2017). Proper training should include detailed documentation of each 
incidence of CIs, as a recent study reported that 36% of CIs were not recorded (Thomann, 
Zwakhalen, Richter, Bauer, & Hahn, 2020). Another approach is immediate staff debriefing, 
following the application of CIs. This process allows staff to reflect on the recent experience 
with an interdisciplinary team, and may reduce the staff trauma associated with the event as well 
as CI use moving forward (Mangaoil, Cleverley, & Peter, 2020). These clinical tools and 
approaches, if applied consistently in clinical practice, can improve the patient quality of care. 
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5.2 Policy Implications  
The province has been moving towards a least restraint approach over the past decade. 
High quality clinical information, acquired through validated clinical tools and strategies, is 
needed to ensure that CI use remains exclusively for acute safety issues. However, the 
application of behaviour management techniques, CAPs or immediate staff debriefing may 
require additional staff and resources. For example, allowing staff to interrupt their workflow 
and engage in a multidisciplinary debrief may be unrealistic, moreover including a management-
level debrief with a facilitator was identified as the best practice for this method (Mangaoil et al., 
2020). Similarly, while the assessment tools used in this study could be beneficial in clinical 
care, they are not mandated for use across the province. Unfortunately, mental health resources 
are limited for adult psychiatric services as mental health care in Canada is underfunded 
compared to other OCED countries (Centre for Addiction and Mental Health, 2021). Therefore, 
an effective policy would include both the standardization of assessment tools coupled with 
adequate financial resources and staff training to be effective. Improving patient outcomes by 
reducing CI use has positive implications for recovery and a lowered risk of readmission. As 
such, prioritizing preventative approaches to psychiatric care would be beneficial for both 
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5.3 Future Research 
While the aim in acute psychiatric care is not a 0% prevalence of CIs, more research is 
needed to determine whether current rates of CI use are reasonable. One potential area of 
research would be to use the available data to assess GDs in the use of CIs across difference 
facilities in Ontario. A facility analysis would evaluate whether these GDs are systematic, or is 
different patterns exist in certain pockets in the network, thus providing potential targets for 
quality improvement achieved through staff education and training. This analysis would require 
information on case-mix of facilities for accurate benchmarking. As previously mentioned, more 
research is needed to determine how often the application of a CI is used as a “last resort”, in 
addition to developing criteria to guide health care staff could eliminate subjectivity in this 
practice. An interesting qualitative study would examine which combinations of individual 
behaviours are perceived as more threatening and may increase the likelihood of experiencing 
CIs. A future study examining combined interaction models between gender and demographic, 
clinical and behavioural variables is needed to compare CI use between genders for both violent 
and non-violent patients. More research is needed the case mix of other groups to make 
comparisons between genders and on whether targeting predictors of CIs are effective in 
reducing the odds of CI use, in particular among men. Finally, it may be useful to examine how 
using alternative cut points for CAPs, scales and age groups, among other variables, may 
influence the odds of CIs. Gender should continue to be used as a stratification variable to assess 
issues of equity with risk adjusters for risk of harm to others, conflict and other variables 
contributing to the odds of CI. 
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6.0 Limitations 
A limitation of the RAI-MH assessment is that it does not fully capture gender identity. 
The assessment is done in hospital so it may be that clinic staff will indicate the patient’s gender 
on their behalf without providing opportunity to elaborate on their gender identity. While 
OHMRS is developing a more comprehensive gender measure, it is possible that this cell count 
for less common gender identifies will remain too small to use in statistical analysis, due to 
residual disclosure. However, this challenge does not take away the clinical value of a more 
comprehensive gender measure in improving quality of care to non-binary patients. In addition, 
this study would have been strengthened by including variables that interact with gender, such as 
race, ethnicity, and disability as a part of the analysis (Statistics Canada, 2018). However, it is 
not possible to incorporate these variables in analysis without data linking from another source, 
which fell beyond the scope of these thesis. Another limitation of this study was that it did not 
examine a combined interactions model assessing differential odds of restraint between violent 
and non-violent men and women. Future research examining the interactions between variables 
is needed. Finally, there is no information on staff characteristics or mix. It would be interesting 
to know if gender of staff may interact with the decision to restrain. As well, considering the 
nature and compounding effect of behaviours would have provided more information on how 









Behaviours and clinical symptoms are associated with the odds of control interventions. 
In general, men experience control interventions compared to women, however, gender 
differences to exist in the odds of experiencing CIs. Good quality clinical assessments, such as 
the CAPs and scales used in this study, add value to clinical planning and, if employed 
consistently guide treatment approaches. Continued evaluation of least-restraint care and future 
research is necessary to assess whether there is potential to further reduce the prevalence of CIs, 
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Table 10  Description of RAI-MH Scales 
Scale Description Individual Items Included Scale Values Value Descriptions 
Aggressive Behaviour 
Scale (ABS)  
 
Measure of frequency and 
diversity of aggressive 
behaviours  
 
Verbal abuse, physical abuse, socially 










Scale (CPS)  
 
Describes the person’s 
cognitive status 
Short-term memory, daily decision-making, 
self-performance in eating, and ability to 








Moderate impairment  




An alternative measure to 
Depression Rating Scale for 
symptoms of depression  
Sad and pained facial expressions, negative 












A measure of frequency of 
symptoms of mania  
 
Inflated self-worth, hyper-arousal, 
irritability, increased sociability/hyper-
sexuality, pressured speech, labile affect, 







Moderate mania  
Severe mania 
Positive Symptoms 
Scale (PSS): short  
 
A measure of the frequency 
of positive symptoms  
 
History of suicide attempts, positive 
symptoms scale, depressive severity scale, 
family concerned re: self-injury, cognitive 






Mild Levels of PSS 
Moderate Levels of PSS  
Severe Levels of PSS 
Risk of Harm to 
Others (RHO)  
 
A measure that reflects the 
risk of harm to others  
 
ABS, PSS long, violence summary scale 
(VSS), sleep problems, insight into mental 









Severity of Self-harm 
(SoS)  
 
Reflects risk of harm to 
oneself  
 
History of suicide attempts, positive 
symptoms scale, depressive severity scale, 
family concerned re: self-injury, cognitive 






Mild Risk of Self-Harm  
Moderate Risk of Self-Harm 
Severe Risk of Self-Harm 
Note: These scales can be used to evaluate an individual's current clinical status over time and can also be evaluated and compared. Each scale has 
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Appendix A - Summary of Scales and CAPS Con^t  
 
Table 11  Description of RAI-Mental Health Clinical Assessment Protocols (CAPs) 
 
Category CAP Scale Values Value Descriptions 






Identifies those who are at: 
Low risk of harming to others 
Moderate risk of harming to others 
High risk of harming to others 
 







Identifies those who are at: 
Low risk of suicide or intentional self-harm 
Moderate risk of suicide or intentional self-harm 
High risk of suicide or intentional self-harm 
 






Identifies those who are at: 
Low risk of experience conflict with others 
Moderate risk of experience conflict with others 
High risk of experience conflict with others 
 






Identifies those are at risk/experience: 
Low social isolation/family dysfunction 
Moderate social isolation/family dysfunction 
High safety social isolation/family dysfunction 
 






Identifies those who experienced: 
Low safety needs or ongoing impact of prior trauma 
Moderate safety needs or ongoing impact of prior trauma 
High safety needs or ongoing impact of prior trauma 
 





Identifies those who are at: 
Low risk of violent/nonviolent criminal behaviour 
High risk of violent/nonviolent criminal behaviour  
Health Promotion Substance Use ** 





Identifies those who have: 
Low risk of abusing substances 
Moderate risk of abusing substances 
High risk of abusing substances 
 
Note: A CAPs support clinical decision making by identifying to whether and how to intervene can be explored with the individual 
* Includes ongoing hostility and criticism 
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Appendix B - Literature Search Results 
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Appendix B – Literature Search Results Con^t 
 
Table 12 Relevant Articles Results Table - Gender Differences in Psychiatric Treatment  











differences in patient 
satisfaction and 
expectation for care 
provided by 
psychiatrists  







Patient Satisfaction Men reported greater satisfaction with 
psychiatric care compared to females, 
with the greatest satisfaction being 
reported in the 18-35 age group. Males 
also expected more of their physicians  
Quality of Diabetes 










Vigod, 2017  
Determine whether 
quality of diabetes 
care differs between 
men and women with 
chronic psychotic 
illness  












75% of individuals with psychotic 
illness did not receive the minimum 
number of diabetes-related tests as 
recommended by national guidelines. 
Women received better care than men 
Disparities by Sex 
Tracked in the 2015 
National Healthcare 
Quality and 




Moy, 2018  
Analyze sex 
differences and trends 
in health care access 





men and women in 
the US (18+). 






Mental Health Care 
Access 
Women received worse care than men 
20% of the time. Women experience 
more barriers to care, in particular 
financial barriers or inconsistent health 
coverage. Women required more 
services to achieve similar outcomes 
Gender and the 
relative importance 
of mental health 





Sarkin, 2014  
Investigate the 
relationship between 
gender, mental health 
service domains and 
satisfaction 
  










Quality of life, 
Clinical Status  
Relationship between satisfaction and 
access to services, social connectedness 
and improved functioning was stronger 












Explore what impacts 
metabolic monitoring 
guidelines of patients 
receiving 
antipsychotics in 












Patient’s gender was the only 
characteristic associated with the 
number of assessed metabolic 
parameters prior to antipsychotic 
prescription, which was significantly 














therapy of LGBT 
individuals  
42 USA LGBT 








Client-level variables, service-level 
variables and therapist behaviors 
(availability) affect LGBT individuals’ 
experiences in therapy 
  
Differences in 
Depression Care for 





Lam et al., 
2017  
Assesses the gender 
differences in 
depression care 
















within 30 days  
Women had better rates of depression 
care (follow-up, appropriate 
prescription, psychotherapy visits, 
specialist visits, diagnosis within 180 
days of first visit) than men. 
 
 
